WO2007095032A3 - Mutations and polymorphisms of ptk2b - Google Patents
Mutations and polymorphisms of ptk2b Download PDFInfo
- Publication number
- WO2007095032A3 WO2007095032A3 PCT/US2007/003280 US2007003280W WO2007095032A3 WO 2007095032 A3 WO2007095032 A3 WO 2007095032A3 US 2007003280 W US2007003280 W US 2007003280W WO 2007095032 A3 WO2007095032 A3 WO 2007095032A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ptk2b
- mutations
- mutant
- polymorphisms
- various aspects
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Abstract
This invention relates generally to the analytical testing of tissue samples in vitro, and more particularly to aspects of genetic polymorphisms and mutations of the PTK2B gene. The invention provides new PTK2B mutations and SNPs, useful in the diagnosis and treatment of subjects in need thereof. Accordingly, the various aspects of the present invention relate to polynucleotides encoding the PTK2B mutations of the invention, expression vectors encoding the PTK2B mutant polypeptides of the invention and organisms that express the PTK2B mutant and polymorphic polynucleotides and/or PTK2B mutant/polymorphic polypeptides of the invention. The various aspects of the present invention further relate to diagnostic/theranostic methods and kits that use the PTK2B mutations and polymorphisms of the invention to identify individuals predisposed to disease or to classify individuals with regard to drug responsiveness, side effects, or optimal drug dose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77177506P | 2006-02-09 | 2006-02-09 | |
US60/771,775 | 2006-02-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007095032A2 WO2007095032A2 (en) | 2007-08-23 |
WO2007095032A3 true WO2007095032A3 (en) | 2008-02-28 |
Family
ID=38050961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/003280 WO2007095032A2 (en) | 2006-02-09 | 2007-02-07 | Mutations and polymorphisms of ptk2b |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007095032A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112695081B (en) * | 2020-12-30 | 2022-08-26 | 中国医学科学院北京协和医院 | New susceptibility gene of primary biliary cholangitis and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030143606A1 (en) * | 2000-06-30 | 2003-07-31 | Alexander Olek | Diagnosis of diseases associated with the immune system by determining cytosine methylation |
-
2007
- 2007-02-07 WO PCT/US2007/003280 patent/WO2007095032A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030143606A1 (en) * | 2000-06-30 | 2003-07-31 | Alexander Olek | Diagnosis of diseases associated with the immune system by determining cytosine methylation |
Non-Patent Citations (6)
Title |
---|
ANONYMOUS: "Kinase Variation Sequence Program", INTERNET ARTICLE, 2005, XP002448903, Retrieved from the Internet <URL:http://web.archive.org/web/20050205011923/http://agencourt.com/services/kinase> [retrieved on 20070901] * |
DATABASE GENECARDS [online] 2007, "PTK2B protein tyrosine kinase 2 beta", XP002448904, Database accession no. PTK2B * |
DATABASE SNP [online] 2003, "Cluster Report: rs1030526", XP002448905, Database accession no. rs1030526 * |
LIU C ET AL: "SNP fine mapping of chromosome 8p21-12 reveals four potential candidate genes for schizophrenia, DPYSL2, TRIM35, PTK2B, and CHRNA2", AMERICAN JOURNAL OF MEDICAL GENETICS. PART B, NEUROPSYCHIATRIC GENETICS, WILEY-LISS, HOBOKEN, NJ, US, vol. 138B, no. 1, September 2005 (2005-09-01), pages 126, XP009088866, ISSN: 1552-485X * |
NAYLOR TARA L ET AL: "High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization", BREAST CANCER RESEARCH, CURRENT SCIENCE, LONDON, GB, vol. 7, no. 6, 24 November 2005 (2005-11-24), pages R1186 - R1198, XP021011919, ISSN: 1465-5411 * |
STITZIEL NATHAN O ET AL: "A Protein Kinase Database for Genes Expressed in Human Bone Marrow: Application to Hematologic Malignancies.", BLOOD, vol. 100, no. 11, 16 November 2002 (2002-11-16), & 44TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; PHILADELPHIA, PA, USA; DECEMBER 06-10, 2002, pages Abstract No. 2905, XP009088868, ISSN: 0006-4971 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007095032A2 (en) | 2007-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007016532A3 (en) | Mutations and polymorphisms of hdac4 | |
WO2006130527A3 (en) | Mutations and polymorphisms of fibroblast growth factor receptor 1 | |
WO2009132058A3 (en) | Levels of bcma protein expression on b cells and use in diagnostic methods | |
NZ600235A (en) | Methods and compositions for the assessment of drug response | |
WO2005033652A3 (en) | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol | |
MX2010006484A (en) | Compositions and methods of detecting tiabs. | |
WO2010053587A3 (en) | Methods of monitoring conditions by sequence analysis | |
WO2006105252A3 (en) | Diagnosis of chronic pulmonary obstructive disease and monitoring of therapy using gene expression analysis of peripheral blood cells | |
WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
WO2008122670A3 (en) | Human diabetes susceptibility tnfrsf10b gene | |
NZ596614A (en) | Diagnosis and treatment of alzheimer's disease | |
WO2006110478A3 (en) | Mutations and polymorphisms of epidermal growth factor receptor | |
EP2287340A3 (en) | Method for diagnosis and treatment of a mental disease | |
WO2005118403A3 (en) | Methods for detecting gene expression in peripheral blood cells and uses thereof | |
MX2007008984A (en) | Cancer markers and detection methods. | |
WO2008132763A3 (en) | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction | |
WO2007022041A3 (en) | Mutations and polymorphisms of hdac3 | |
ATE461294T1 (en) | BREAST CANCER DIAGNOSTIC PROCEDURES | |
WO2007030455A3 (en) | Mutations and polymorphisms of hdac10 | |
WO2007038073A3 (en) | Mutations and polymorphisms of hdac11 | |
WO2007030454A3 (en) | Mutations and polymorphisms of hdac9 | |
WO2007058992A3 (en) | Mutations and polymorphisms of hdac6 | |
WO2009133197A3 (en) | Levels of april in serum and use in diagnostic methods | |
WO2007109183A3 (en) | Mutations and polymorphisms of fms-related tyrosine kinase 1 | |
WO2007002217A3 (en) | Mutations and polymorphisms of bcl-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07750148 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07750148 Country of ref document: EP Kind code of ref document: A2 |